The Powell Perspective

Italian luxury knitwear maker Zanieri completes a reverse merger with Everlert, Inc., gaining a US public listing to fund global expansion and brand growth.

With revenue up but clients down, Stitch Fix leadership must convince investors at the ICR conference that its AI-driven strategy can deliver growth.

A private tender offer values diagnostics firm PathoCare at $1.75B. Can its AI-powered, non-invasive technology justify the price and transform medicine?

Arizona State University just crossed $1 billion in research spending. This is the story of its disruptive rise and what it means for health, defense, and AI.

A state-owned Chinese automaker selects Arbe Robotics' ultra-high-res radar via Hirain for its L4 program, signaling a major leap for autonomous safety.

Syntiant unveils ultra-thin AI chips for hearables and smart remotes, aiming to dominate the booming market for miniaturized intelligent devices.

Pembroke's acquisition of the 280-unit Proto tower in Cambridge marks a strategic pivot to residential real estate in its founding city of Boston.

In a landmark deal, BioMarin acquires Amicus Therapeutics, gaining high-growth drugs and reshaping the landscape for patients with rare genetic disorders.

National homebuilder Toll Brothers opens Bethany Farms in Simpsonville, tapping into the area's hot luxury market with customizable homes and amenities.

As Leverage Shares by Themes launches seven new 2x daily leveraged ETFs, a look at the high-stakes game of amplified returns and the risks for investors.

An international expert panel endorses an advanced wound therapy, potentially revolutionizing patient recovery and boosting a key player in the med-tech market.

The CT Plan selects DataCT as its independent administrator, a critical step in a sweeping SEC-mandated overhaul of market data set for 2027.

The iGaming supplier launches 80 exclusive games in Brazil's new regulated market, a strategic move to capture growth in Latin America's largest economy.

Subsea 7 has landed a contract worth up to $300M for Chevron's Gorgon Stage 3 project, reinforcing its key role in Australia's deepwater energy sector.

Odysight.ai's new sensors offer a live video feed from inside hot, oil-filled machinery, a breakthrough poised to transform industrial predictive maintenance.

Quince Therapeutics' Phase 3 trial completion for Ataxia-Telangiectasia offers hope, but the real story is its innovative red blood cell drug delivery platform.

A key 2026 legal forum reveals the DOJ's expanding False Claims Act focus, putting cybersecurity non-compliance and private equity investors on notice.

Beyond the dividend payout, Cherry Hill Mortgage's strategy reveals a deeper pivot towards digital innovation, balancing high yields with new frontiers of risk.

Genmab's $8 billion acquisition of Merus isn't just a deal; it's a bold strategy to own its destiny and dominate the future of oncology therapeutics.

Lion Group's $8M Bitcoin purchase highlights a growing corporate trend, but a plunging stock price reveals the immense risks of digital asset treasuries.